Fibroids

Agency approves new device to treat fibroids

Published in Women's Health Weekly, November 11th, 2004

A device that treats fibroids through a combination of ultrasound and magnetic resonance imaging won approval Friday from the U.S. Food and Drug Administration (FDA).

Fibroids are non-cancerous masses that occur in the uterus that can affect between 20% and 40% of woman over 35. Some have no symptoms, but others experience heavy and prolonged menstrual periods, pain in the back, legs or pelvis, pressure on the bladder or bowels and pain during sexual intercourse.

The FDA said it gave expedited approval to ExAblate because it offers major advantages over other treatments for fibroids.

The device is intended for use on women who...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2004-11-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry